Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Boundless Bio, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
BOLD
Nasdaq
2836
boundlessbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Boundless Bio, Inc.
Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
- Jun 5th, 2025 2:58 pm
Boundless Bio Announces Portfolio Prioritization and Runway Extension
- May 23rd, 2025 2:01 pm
Boundless Bio, Inc. (BOLD) Upgraded to Buy: Here's What You Should Know
- May 14th, 2025 10:00 am
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
- May 9th, 2025 5:00 am
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
- Apr 3rd, 2025 5:00 am
Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
- Mar 27th, 2025 5:00 am
Here's Why We're Watching Boundless Bio's (NASDAQ:BOLD) Cash Burn Situation
- Mar 6th, 2025 6:07 am
Boundless Bio to Participate in the Leerink Global Healthcare Conference
- Feb 26th, 2025 5:00 am
Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer
- Feb 3rd, 2025 8:00 am
Boundless Bio Announces Pipeline and Leadership Updates
- Dec 12th, 2024 2:01 pm
Boundless Bio to Participate in the Piper Sandler Healthcare Conference
- Nov 25th, 2024 5:00 am
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
- Nov 7th, 2024 2:01 pm
Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference
- Nov 5th, 2024 5:00 am
Boundless Bio Announces Departure of Chief Financial Officer
- Oct 14th, 2024 6:00 am
Is Boundless Bio (NASDAQ:BOLD) In A Good Position To Invest In Growth?
- Sep 27th, 2024 6:52 am
Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference
- Sep 11th, 2024 5:00 am
Boundless Bio, Inc. (BOLD): Why Should You Buy This New Penny Stock Now?
- Aug 13th, 2024 1:32 am
Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results
- Aug 12th, 2024 2:01 pm
Scroll